Results 1 to 10 of about 1,249 (115)

Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria [PDF]

open access: yesBMC Infectious Diseases, 2005
Background The increasing problem of infections due to multidrug-resistant Gram-negative bacteria has led to re-use of polymyxins in several countries.
Bliziotis Ioannis A   +5 more
doaj   +5 more sources

Extensively Drug-Resistant (XDR) and Pandrug-Resistant (PDR) Acinetobacter baumannii as Sentinel Indicators of Cumulative System-Level Antimicrobial Pressure in Iraqi Burn and High-Risk Hospital Units [PDF]

open access: yesMicroorganisms
Antimicrobial resistance (AMR) is one of the most significant threats to healthcare systems, particularly in low- and middle-income nations where infection prevention and control, antimicrobial stewardship, and laboratory surveillance might not be ...
Sarah Ahmed Hasan   +2 more
doaj   +3 more sources

The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa [PDF]

open access: yesJournal of Medical Microbiology, 2006
Different definitions of the terms multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa have been used in the biomedical literature. The authors searched for relevant studies indexed in the PubMed database (01/2000–09/2005) to systematically examine the various definitions of MDR and PDR for these ...
Ioannis Bliziotis, Matthew Falagas
exaly   +3 more sources

Characteristics and risk factors of postoperative pneumonia after emergency surgery in tertiary general hospitals (2015–2024): a 10-year comparative analysis with elective surgery [PDF]

open access: yesFrontiers in Public Health
ObjectiveTo analyze the characteristics and risk factors of postoperative pneumonia (POP) in emergency surgery at tertiary general hospitals, aiming to provide scientific evidence for early screening of high-risk populations and optimization of POP ...
Zhenzhen Wu   +8 more
doaj   +2 more sources

Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients

open access: yesAntibiotics, 2022
Carbapenem resistance in Gram-negative bacteria has come into sight as a serious global threat. Carbapenem-resistant Gram-negative pathogens and their main representatives Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa are ...
Helen Giamarellou, Ilias Karaiskos
doaj   +3 more sources

Clinical treatment of pandrug-resistant bacterial infection consulted by clinical pharmacist

open access: yesSaudi Pharmaceutical Journal, 2015
Objective Pandrug-resistant (PDR) bacterial infections are associated with considerable prolongation of hospitalization and mortality in clinical practice. Method This case-series study was conducted during a 3-year period from 2011 to 2013.
Yang Zhi-Wen   +3 more
doaj   +2 more sources

Burden of extensively drug-resistant and pandrug-resistant Gram-negative bacteria at a tertiary-care centre

open access: yesNew Microbes and New Infections, 2015
The emergence of resistance to multiple antimicrobial agents in Gram-negative bacteria is a significant threat to public health, as it restricts the armamentarium of the clinician against these infections.
Puneet Bhatt   +3 more
doaj   +3 more sources

Lessons from Four Years (2021–2024) of Klebsiella Pneumoniae Resistance Surveillance Epidemiological Trends in a Romanian Intensive Care Unit [PDF]

open access: yesAntibiotics
Background: Klebsiella pneumoniae represents a major cause of healthcare-associated infections in intensive care units, with resistance profiles ranging from multidrug-resistant to extensively drug-resistant and pandrug-resistant. Critically ill patients,
Mihai Sava   +4 more
doaj   +2 more sources

Trends in Antimicrobial Resistance at a Greek Tertiary Hospital over a 7-Year Period, Including the COVID-19 Pandemic [PDF]

open access: yesAntibiotics
Background/Objectives: Antimicrobial resistance (AMR) remains a major global threat, with the COVID-19 pandemic influencing its dynamics, although its overall impact remains uncertain.
Eleni Mylona   +9 more
doaj   +2 more sources

Phage Therapy as an Alternative Strategy Against Pseudomonas aeruginosa: A Narrative Review of Preclinical and Clinical Evidence [PDF]

open access: yesMicrobiologyOpen
Pseudomonas aeruginosa is an opportunistic pathogen and one of the main causes of nosocomial infections. This pathogen affects immunocompromised individuals such as patients with chronic wounds or cystic fibrosis.
Gustavo Aparecido da Cunha   +7 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy